Skip to main navigation Skip to search Skip to main content

Long-term effects of perinatal glucocorticoid treatment on the heart

  • Willem B. de Vries*
  • , Matthijs F.M. van Oosterhout
  • , Miriam P. Bal
  • , Jan Baan
  • , Cobi J. Heijnen
  • , Frank van Bel
  • *Corresponding author for this work
  • Utrecht University
  • Leiden University

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Chronic lung disease in the extremely preterm baby is still a major complication in neonatal intensive care. Perinatal (ante- and neonatal) glucocorticoids are widely used to prevent severe infant respiratory distress syndrome and/or to reduce chronic lung disease respectively. A review of the literature regarding the cardiovascular side effects of antenatal and neonatal glucocorticoids is presented here.

Original languageEnglish
Pages (from-to)190-197
Number of pages8
JournalCurrent Pediatric Reviews
Volume3
Issue number3
DOIs
Publication statusPublished - Aug 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Betamethasone
  • Chronic lung disease
  • Hypertrophy
  • Protein/DNA ratio
  • Respiratory Distress Syndrome

Fingerprint

Dive into the research topics of 'Long-term effects of perinatal glucocorticoid treatment on the heart'. Together they form a unique fingerprint.

Cite this